The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
Global dermatology market set to grow from $20 billion in 2015 to $33.7 billion by 2022, at a compound annual growth rate of 7.7%. This strong growth will be driven by a robust late-stage pipeline, including valuable targeted therapies such as dupilumab and ixekizumab, says analyst
The Russian government has designed a new package of measures aimed at providing support to domestic drugmakers as well as global majors, operating their plants within the country.
Walgreens Boots Alliance has bought a 15 percent stake in a Russian pharmacy chain. According to Russian pundits, the country’s commercial drug market can be very promising for foreign investors.
Japanese research and development pharmaceutical company Eisai and PharmStandard, a leading Russian pharmaceutical company, today announce that they have signed Cooperation Agreements relating to the localised production of Eisai products in Russia.
1 - 5 из 834
PJSC Pharmsynthez , a St. Petersburg, Russia based pharmaceutical company developing next generation vaccines and biologics has completed follow up and data analysis from a first-in-human, proof-of-concept and dose-escalation study of CD206-targeted proprietary liposomal oligopeptides in multiple sclerosis (MS) patients who are resistant to first-line disease modifying therapies
Начало | Пред. |
programmer of electronic software products